For laboratory & research use only — not for human or veterinary use

Same-day shipping on orders by 2pm EST

USA sourced · USA shipped

Free shipping on orders over $150

4.9/5 from 1,200+ verified researchers

≥99% purity — HPLC + mass spec

Endotoxin tested · sterility verified

COA on every batch

Heart health

Show your heart some love

Up to 80% of heart disease may be preventable. Go beyond cholesterol with proactive support across five connected parts of heart health, built into one plan.

Cardiovascular compounds, grouped by how they work

Research-use-only material, organised by the lever each compound acts on. Every compound links through to its product page, where the available sizes and lot documentation are listed.

Statin

Atorvastatin tablet

Atorvastatin

Once-daily statin studied for lowering LDL and ApoB, the reference lever for reducing plaque-forming particle exposure over time.

ARB

Telmisartan tablet

Telmisartan

24-hour angiotensin receptor blocker studied for blood pressure control and cardiovascular risk reduction in high-risk populations.

PDE5

Tadalafil tablet

Tadalafil for Longevity

Low daily dose studied for endothelial function and blood flow to the heart, brain, muscles and organs. The once-daily circulation lever.

Antioxidant

Glutathione vial

Glutathione Injection

The body’s master antioxidant, studied for cellular defence against oxidative stress that shapes vascular ageing over time.

GLP-1

Semaglutide vial

Microdosing Semaglutide

Low-dose GLP-1 protocol studied for glucose regulation and metabolic risk factors that connect back to cardiovascular disease.

SGLT2

SGLT2 tablet

SGLT2 Inhibitor

Once-daily SGLT2 inhibitor investigated for glucose handling and the cardiometabolic pathways that connect diabetes and heart failure risk.

Five connected parts of heart health

Cardiovascular risk is not one number. Cholesterol, blood pressure, circulation, oxidative stress and metabolic control each move independently, and each has its own studied lever.

Our catalogue is organised by mechanism rather than by brand, so a protocol can be designed around the lever the baseline labs point to instead of whichever compound is trending.

01

Cholesterol

Statins like atorvastatin lower LDL and ApoB, reducing the plaque-forming particles circulating through the arterial wall.

02

Blood pressure

ARBs like telmisartan relax vessels and reduce the pressure the heart and arteries carry across a 24-hour window.

03

Circulation

Low-dose tadalafil supports endothelial responsiveness and blood flow to the heart, brain, muscles and organs.

04

Oxidative stress

Glutathione supports antioxidant defences studied for protecting cells against the oxidative load that shapes vascular ageing.

Reference calculator

What LDL reductions look like in the literature

Set a baseline LDL and see the range reported across published atorvastatin dose-ranging trials. It is a modelling aid for study design, not a prediction.

100 mg/dL220 mg/dL

Baseline LDL

160 mg/dL

Reported range

62–120 mg/dL

25–61% reduction reported across dose-ranging trials

Heart protection that builds over time

2 weeks

2 weeks

Blood pressure and cholesterol may begin shifting as telmisartan relaxes vessels and atorvastatin starts blunting cholesterol production.

30 days

30 days

Atorvastatin approaches near-full effect, with fewer LDL and ApoB particles circulating with the potential to enter artery walls.

3 months

3 months

Labs may reveal meaningful reductions in LDL and ApoB; home readings may show blood pressure stabilising into healthier ranges.

6 months

6 months

More time in healthier ranges means less cumulative exposure to plaque-forming particles and elevated pressure that shape long-term risk.

1 year+

1 year+

Protection compounds. Every 39 mg/dL reduction in LDL is linked to 20% fewer major events; better blood pressure has reduced risk by 20 to 25% in major trials.

Compare

Four levers side by side

AtorvastatinTelmisartanTadalafil DailyGlutathione
Primary leverCholesterol (LDL, ApoB)Blood pressureCirculation / endothelialOxidative stress
DeliveryOral tabletOral tabletOral tabletInjection
FrequencyOnce dailyOnce dailyOnce dailyWeekly
Reported effect25–61% LDL reductionSuperior 24-hr BP control60% lower MACE (highest quartile)Antioxidant capacity restored
Time to near-full effect≈30 days2–4 weeks2–4 weeks daily4–8 weeks

Figures describe published trial literature for the reference compounds, not outcomes from BuyTides material. Products are supplied for laboratory research use only and are not for human or veterinary use.

Reading before you design the study

Lp(a) article

Cardiometabolic

Lp(a): the best-kept secret to heart health

The lipoprotein few standard panels look at, and why longevity researchers keep coming back to it.

Read more

Prevention article

Prevention

Can you reverse heart risk?

How lifestyle levers and pharmacology stack, and what the trials actually show about turning the curve.

Read more

Atorvastatin article

Mechanisms

What is atorvastatin, exactly?

How the reference statin works, who it is studied in, and what the dose-response curve actually looks like.

Read more

Questions we get most

Which lever should a first protocol target?

Most researchers begin with the lever the baseline labs point to: LDL and ApoB for cholesterol, resting blood pressure for pressure, endothelial markers for circulation. Because pressure, lipids and circulation move independently, a first protocol often ends up combining more than one compound rather than escalating a single dose.

How is purity established for each lot?

Every lot is tested by an independent laboratory using HPLC for purity and mass spectrometry for identity. The certificate of analysis is attached to the lot number in your account before the order ships, and it stays downloadable indefinitely.

How is the material shipped and stored?

Oral tablets ship at ambient temperature; injectables and lyophilised material dispatch within 24 hours in insulated cold-chain packaging. Storage guidance and stability windows are printed on every certificate of analysis.

How do statins, ARBs and PDE5 inhibitors differ in what they study?

Each acts on a different piece of cardiovascular health. Statins like atorvastatin target LDL and ApoB. ARBs like telmisartan target vascular tone and blood pressure. PDE5 inhibitors like tadalafil target endothelial responsiveness and blood flow. Many protocols study more than one at a time because the pathways do not move together.

Who can order from this category?

Ordering requires a registered account with a valid doctor referral code, and the account holder must certify that all material is handled for laboratory research use only. Nothing sold here is for human or veterinary use.

From the journal

More on Heart Health

Lipids, blood pressure and the cardiovascular markers worth tracking year to year.

  • ApoB versus LDL-C: which number to follow

    Particle count tracks risk more closely than cholesterol mass. Here is how to read both.

    7 minRead
    LipidsTopic

    By • BuyTides Medical Team Coming soon

  • Lp(a) is largely inherited, and worth testing once

    A single lifetime measurement changes how aggressively everything else gets managed.

    6 minRead
    RiskTopic

    By • BuyTides Medical Team Coming soon

  • Zone 2 training and cardiovascular reserve

    Three hours a week at a conversational pace does more for the heart than any single session.

    8 minRead
    TrainingTopic

    By • BuyTides Medical Team Coming soon